ArticlePloS one2025
The evolution of comorbidities in chronic diseases among Chinese middle-aged and elderly people: Evidence from the CHARLS (2015-2020).
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Challenges faced and countermeasures implemented by county-level hospitals in China.Journal of global health · 2026Article
- Ten-year trends and influencing factors of hospitalization costs in chronic obstructive pulmonary disease: a quantile regression analysis (2016-2025).Frontiers in health services · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe comorbidity of chronic diseases among middle-aged and elderly people is a global public health concern that has attracted great attention in recent years. It is crucial to explore the evolutionary pattern of chronic disease comorbidity in Chinese middle-aged and elderly people and to reveal the developmental trajectory of chronic diseases in this population.
methodsData from the China Health and Retirement Longitudinal Study (CHARLS 2015-2020) were utilized for the fixed cohort analysis. Based on the prevalence information of 14 chronic diseases (including hypertension, dyslipidemia, diabetes, cancer, chronic lung diseases, liver disease, heart disease, stroke, kidney disease, stomach diseases, emotional problems, memory-related diseases, arthritis, and asthma) among 10,089 participants aged ≥45 years, association rules and cluster analysis were used to identify trends and trajectories of comorbidities in the middle-aged and elderly populations in China.
resultsThe analysis revealed that the comorbidity rate of the 14 chronic diseases showed a consistent annual increase from 2015-2020. By 2020, over 85% of patients diagnosed with a single chronic condition exhibited concurrent multimorbidity. This epidemiological progression was paralleled by a progressive increase in detected disease associations: binary comorbidities rose from three significant associations in 2015-10 in 2020, whereas higher-order combinations expanded from one ternary association in 2015-35 ternary and 18 quaternary associations by 2020. Notably, hypertension maintained a central position across all identified comorbidity clusters. The comorbidity patterns identified in 2015 included respiratory, liver and kidney, and cardio-cerebral comorbidity patterns and cancer and emotional problems. The comorbidity patterns identified in 2018 included respiratory, liver and kidney, cerebrovascular, and cardiovascular metabolic comorbidity patterns. The comorbidity pattern in 2020 was the same as that in 2018.
conclusionThe issues of comorbidities in chronic diseases among Chinese middle-aged and elderly people is significant, with observed variations in the comorbidity patterns across different time periods. The development of clinical assessment and management guidelines for chronic diseases comorbid with key conditions, such as hypertension and dyslipidemia, is recommended. These guidelines aim to facilitate the co-management, co-treatment, and co-reduction of multiple diseases among middle-aged and elderly people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.